Varlilumab (INN; development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies.Statement On A Nonproprietary Name Adopted By The USAN Council - Varlilumab, American Medical Association. It is an anti-CD27 antibody and helps activate T-cells.
